The Cooper Companies, Inc. (COO)
| Previous close | 341.21 |
| Open | 343.65 |
| Bid | 337.97 x 1000 |
| Ask | 338.16 x 1100 |
| Day's range | 334.38 - 345.34 |
| 52-week range | 309.43 - 463.59 |
| Volume | |
| Avg. volume | 323,016 |
| Market cap | 16.696B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 17.98 |
| EPS (TTM) | 18.83 |
| Earnings date | 02 Jun 2022 |
| Forward dividend & yield | 0.06 (0.02%) |
| Ex-dividend date | 20 Jan 2022 |
| 1y target est | 471.00 |
- Zacks
Here's Why You Should Retain Cooper Companies (COO) Stock Now
Cooper Companies (COO) continues to benefit from strength in its business segments.
- Zacks
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -47.06% and 2.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
CooperCompanies to Participate in the Jefferies Healthcare Conference
SAN RAMON, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 9, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:00 PM ET. This webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A webcast replay will be available approximately 48 hours after the live webcast. Ab
